By Professor David Lawson Morris

Journal articles

Bester L; Meteling B; Boshell D; Chua TC; Morris DL, 2014, 'Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: A review of the literature', Journal of Medical Imaging and Radiation Oncology, 58, pp. 341 - 352, http://dx.doi.org/10.1111/1754-9485.12163

Saxena A; Kapoor J; Meteling B; Morris DL; Bester L, 2014, 'Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: A large single-center experience of 40 patients', Annals of Surgical Oncology, 21, pp. 1296 - 1303, http://dx.doi.org/10.1245/s10434-013-3436-1

Amini A; Masoumi-Moghaddam S; Morris DL, 2014, '188: Bromelain and N-acetylcysteine induce cytotoxic effects and reduce the expression of mucin in mucin-producing carcinoma cell lines of gastrointestinal origin', European Journal of Cancer, 50, pp. S43 - S43, http://dx.doi.org/10.1016/s0959-8049(14)50161-x

Bahrami F; Morris DL; Rufener L; Pourgholami MH, 2014, 'Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer', AMERICAN JOURNAL OF CANCER RESEARCH, 4, pp. 545 - 557

Amini A; Masoumi-Moghaddam S; Ehteda A; Morris D, 2014, 'Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro : significance of combination therapy', Journal of Experimental & Clinical Cancer Research, 33, pp. 92 - 92, http://dx.doi.org/10.1186/preaccept-1557435139144520

Bester L; Meteling B; Boshell D; Saxena A; Morris DL, 2014, 'Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancer', HEPATIC ONCOLOGY, 1, pp. 215 - 228, http://dx.doi.org/10.2217/HEP.13.21

Akhter J; Pillai K; Chua TC; Alzarin N; Morris DL, 2014, 'Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters', AMERICAN JOURNAL OF CANCER RESEARCH, 4, pp. 495 - 507

Schwarz L; Votanopoulos K; Morris D; Yonemura Y; Deraco M; Piso P; Moran B; Levine EA; Tuech J-J, 2014, 'La réalisation d’une pancréatectomie gauche au cours d’une chirurgie de cytoréduction avec CHIP est-elle raisonnable ? Résultats d’une étude multicentrique internationale', Journal de Chirurgie Viscérale, 151, pp. A27 - A27, http://dx.doi.org/10.1016/s1878-786x(14)70165-2

Bahrami F; Pourgholami MH; Mekkawy AH; Rufener L; Morris DL, 2014, 'Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway', AMERICAN JOURNAL OF CANCER RESEARCH, 4, pp. 558 - 571

Ung L; Chua TC; Morris DL, 2013, 'Cure for peritoneal metastases? An evidence-based review', ANZ Journal of Surgery, 83, pp. 821 - 826, http://dx.doi.org/10.1111/ans.12306

Ataie-Kachoie P; Pourgholami MH; Morris DL, 2013, 'Minocycline regulates Hypoxia-Inducible Factor-1 alpha expression through the induction of its degradation in ovarian cancer: in vitro and in vivo studies.', MOLECULAR CANCER THERAPEUTICS, 12, http://dx.doi.org/10.1158/1535-7163.TARG-13-A7

Ung L; C. Chua T; L. Morris D, 2013, 'Peritoneal metastases of lower gastrointestinal tract origin: A comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy', Journal of Cancer Research and Clinical Oncology, 139, pp. 1899 - 1908, http://dx.doi.org/10.1007/s00432-013-1517-y

Kirby R; Liauw W; Zhao J; Morris D, 2013, 'Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures', International Journal of Surgical Oncology, 2013, http://dx.doi.org/10.1155/2013/461041

Chua TC; Quinn LE; Zhao J; Morris DL, 2013, 'Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases', Journal of Surgical Oncology, 108, pp. 81 - 88, http://dx.doi.org/10.1002/jso.23356

Yang TX; Billah B; Morris DL; Chua TC, 2013, 'Palliative resection of the primary tumour in patients with Stage IV colorectal cancer: Systematic review and meta-analysis of the early outcome after laparoscopic and open colectomy', Colorectal Disease, 15, pp. e407 - e419, http://dx.doi.org/10.1111/codi.12256

Morris DL, 2013, 'Peritonectomy HIPEC - Contemporary results, indications', Chinese Journal of Cancer Research, 25, pp. 373 - 374, http://dx.doi.org/10.3978/j.issn.1000-9604.2013.07.03

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'MUC1 has prognostic significance in malignant peritoneal mesothelioma', International Journal of Biological Markers, 28, pp. 303 - 312, http://dx.doi.org/10.5301/JBM.5000038

Chan DL; Morris DL; Chua TC, 2013, 'Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-A systematic review', Surgical Oncology, 22, pp. e23 - e30, http://dx.doi.org/10.1016/j.suronc.2013.02.009

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma', Journal of Cancer Research and Clinical Oncology, 139, pp. 987 - 994, http://dx.doi.org/10.1007/s00432-013-1408-2

Pillai K; Akhter J; Chua TC; Morris DL, 2013, 'Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma', Cancer Investigation, 31, pp. 241 - 250, http://dx.doi.org/10.3109/07357907.2013.784777

Ataie-Kachoie P; Pourgholami MH; Morris DL, 2013, 'Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer', Cytokine and Growth Factor Reviews, 24, pp. 163 - 173, http://dx.doi.org/10.1016/j.cytogfr.2012.09.001

Pourgholami MH; Ataie-Kachoie P; Badar S; Morris DL, 2013, 'Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways', Gynecologic Oncology, 129, pp. 113 - 119, http://dx.doi.org/10.1016/j.ygyno.2012.12.031

Koh JL; Liauw W; Chua Dr T; Morris DL, 2013, 'Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy', Journal of Gastrointestinal Oncology, 4, pp. 173 - 181, http://dx.doi.org/10.3978/j.issn.2078-6891.2012.062

Saxena A; Chua TC; Fransi S; Liauw W; Morris DL, 2013, 'Effectiveness of early and aggressive administration of fresh frozen plasma to reduce massive blood transfusion during cytoreductive surgery', Journal of Gastrointestinal Oncology, 4, pp. 30 - 39, http://dx.doi.org/10.3978/j.issn.2078-6891.2012.046

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma', AMERICAN JOURNAL OF CANCER RESEARCH, 3, pp. 411 - 423, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331069400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH, 2013, 'Minocycline targets the NF-κB nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer', Molecular Cancer Research, 11, pp. 1279 - 1291, http://dx.doi.org/10.1158/1541-7786.MCR-13-0239

Saxena A; Morris DL, 2013, 'Mortality and morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis', Viszeralmedizin Gastrointestinal Medicine and Surgery, 29, pp. 231 - 234, http://dx.doi.org/10.1159/000354133

Pillai K; Akhter J; Chua TC; Morris DL, 2013, 'A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei', International Journal of Cancer, http://dx.doi.org/10.1002/ijc.28380

Ehteda A; Galettis P; Pillai K; Morris DL, 2013, 'Combination of Albendazole and 2-Methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice', BMC Cancer, 13, pp. Article number86, http://dx.doi.org/10.1186/1471-2407-13-86

Amini A; Ehteda A; Masoumi S; Moghaddam SM; Akhter J; Pillai K; Morris DL, 2013, 'Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)', OncoTargets and Therapy, 6, pp. 403 - 409, http://dx.doi.org/10.2147/OTT.S43072

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?', AMERICAN JOURNAL OF CANCER RESEARCH, 3, pp. 312 - 322

Kim Y; Pourgholami MH; Morris DL; Lu H; Stenzel MH, 2013, 'Effect of shell-crosslinking of micelles on endocytosis and exocytosis: acceleration of exocytosis by crosslinking', Biomaterials Science, 1, pp. 265 - 275, http://dx.doi.org/10.1039/C2BM00096B

Mekkawy AH; Morris DL, 2013, 'Human sprouty1 suppresses urokinase receptor-stimulated cell migration and invasion.', ISRN Biochem, 2013, pp. 598251, http://dx.doi.org/10.1155/2013/598251

Moghaddam SM; Amini A; Wei AQ; Pourgholami MH; Morris DL, 2013, 'Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines', Journal of Oncology, 2012, pp. Article ID 373826, http://dx.doi.org/10.1155/2012/373826

Chan DL; Morris DL; Chua TC; Rao A, 2013, 'Intraperitoneal chemotherapy in ovarian cancer: A review of tolerance and efficacy', Cancer Management and Research, 4, pp. 413 - 422, http://dx.doi.org/10.2147/CMAR.S31070

Chua T; Quinn L; Zhao J; Morris D, 2013, 'Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Peritoneal Metastases', Annals of Oncology, 24, pp. iv29 - iv29, http://dx.doi.org/10.1093/annonc/mdt202.11

Ataie-kachoie P; Morris DL; Pourgholami MH, 2013, 'Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies', PLoS ONE, 8, pp. Article numbere60817, http://dx.doi.org/10.1371/journal.pone.0060817

Ung L; Chua TC; David L M, 2013, 'Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy.', J Cancer Res Clin Oncol, 139, pp. 1899 - 1908, http://dx.doi.org/10.1007/s00432-013-1507-0

Kirby R; Alzahrani N; Zhao J; Chua T; Liauw W; Morris D, 2013, 'Peritonectomy Results at St.George Hospital, Sydney, Australia at 677 Procedures', Annals of Oncology, 24, pp. iv79 - iv79, http://dx.doi.org/10.1093/annonc/mdt203.151

Bester L; Meteling B; Pocock NA; Saxena A; Chua TC; Morris DL, 2013, 'Radioembolisation with Yttrium-90 microspheres: An effective treatment modality for unresectable liver metastases.', Journal of Medical Imaging and Radiation Oncology, 57, pp. 72 - 80, http://dx.doi.org/10.1111/j.1754-9485.2012.02459.x

Alzahrani N; Chua T; Kirby R; Zhao J; Liauw W; Morris D, 2013, 'Synchrnous Peritonectyomy and Liver Resction in Colorectal Cancer', Annals of Oncology, 24, pp. iv68 - iv68, http://dx.doi.org/10.1093/annonc/mdt203.113

Pelz J; Chua T; Morris D; Esquivel J; Gasser M; Dörfer J; Germer CT; Kerscher A, 2012, 'Welche Rolle spielt die moderne systemische Kombinationschemotherapie in der Behandlung der Peritonealkarzinose eines kolorektalen Karzinoms?', Zeitschrift für Gastroenterologie, 50, http://dx.doi.org/10.1055/s-0032-1323928

Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Elias D; Baratti D; Deraco M; Sardi A; Morris DL, 2012, 'Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.', JOURNAL OF CLINICAL ONCOLOGY, 30, http://dx.doi.org/10.1200/jco.2012.30.4_suppl.532

Khan AB; Al-Suhaibani Y; Al-Mohaimeed K; Morris DL, 2012, 'Application of Advanced Multimodality Care to Pseudomyxoma Peritonei Patient: Report of First Patient Treated at a Tertiary Center', Indian Journal of Surgical Oncology, 1, pp. 270 - 273, http://dx.doi.org/10.1007/s13193-010-0036-4

Chua TC; Morris DL, 2012, 'Colorectal Liver Metastases with Extrahepatic Disease-A New Criteria for Oncologic Resection?', Journal of gastrointestinal cancer, 43, pp. 502 - 504, http://dx.doi.org/10.1007/s12029-011-9278-9

Kim Y; Liemmawal E; Pourgholami MH; Morris DL; Stenzel MH, 2012, 'Comparison of shell-cross-linked micelles with soft and glassy cores as a drug delivery vehicle for albendazole: Is there a difference in performance?', Macromolecules, 45, pp. 5451 - 5462, http://dx.doi.org/10.1021/ma300644v

Ehteda A; Galettis PT; Chu SLW; Pillai KR; Morris DL, 2012, 'Complexation of albendazole with hydroxypropyl-â-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice', Anticancer Research, 32, pp. 3659 - 3666, http://dx.doi.org/

Mirarabshahii P; Pillai K; Chua TC; Pourgholami MH; Morris DL, 2012, 'Diffuse malignant peritoneal mesothelioma - An update on treatment', Cancer Treatment Reviews, 38, pp. 605 - 612, http://dx.doi.org/10.1016/j.ctrv.2011.10.006

Chua TC; Liauw W; Morris DL, 2012, 'Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome', International Journal of Colorectal Disease, 27, pp. 381 - 389, http://dx.doi.org/10.1007/s00384-011-1303-8

Chua TC; Moran BJ; Sugarbaker PH; Levine E; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw WS; Yan TD; Barrios P; Gomez Portilla A; De hingh IH; Ceelen WP; Pelz JO; Piso P; Gonzalez-Moreno S; Van der speeten K; Morris DL, 2012, 'Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.', Journal of Clinical Oncology, 30, pp. 2449 - 2456, http://dx.doi.org/10.1200/JCO.2011.39.7166

Back to profile page